PharmaCielo Ltd.
PCLO.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 974.30K | 572.70K | 178.20K | 179.40K | 262.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 974.30K | 572.70K | 178.20K | 179.40K | 262.20K |
| Cost of Revenue | 701.80K | 371.90K | 473.80K | 338.80K | 522.50K |
| Gross Profit | 272.60K | 200.80K | -295.60K | -159.50K | -260.30K |
| SG&A Expenses | 903.80K | 1.39M | 925.80K | 956.60K | 1.42M |
| Depreciation & Amortization | 34.90K | 37.00K | 69.50K | 45.60K | 60.60K |
| Other Operating Expenses | -26.50K | -16.00K | -1.80K | -- | -29.20K |
| Total Operating Expenses | 1.61M | 1.79M | 1.47M | 1.34M | 1.97M |
| Operating Income | -639.60K | -1.21M | -1.29M | -1.16M | -1.71M |
| Income Before Tax | -1.94M | -1.88M | -1.80M | -4.70M | -2.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.94M | -1.88M | -1.80M | -4.70M | -2.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.94M | -1.88M | -1.80M | -4.70M | -2.06M |
| EBIT | -639.60K | -1.21M | -1.29M | -1.16M | -1.71M |
| EBITDA | -611.20K | -1.18M | -1.22M | -1.12M | -1.44M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 162.03M | 169.75M | 169.30M | 166.25M | 162.03M |
| Average Diluted Shares Outstanding | 162.03M | 169.75M | 169.30M | 166.25M | 162.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
